Table 1 Baseline characteristics
From: Daily use of extracorporeal CO2 removal in a critical care unit: indications and results
Variables | Patients (n = 33) |
|---|---|
Age (years) | 63 [59–68] |
Gender (male/female) | 20/13 |
Body mass index (kg/m2) | 26 [23–30] |
IGS2 score | 49 [36–65] |
SOFA score | |
At ICU admission | 7 [5–10] |
At the time of ECCO2R start | 10 [7–12] |
Indication | |
Mild or moderate ARDS | 16 (48) |
COPD exacerbation | 11 (33) |
Other | 6 (19) |
Associated organ dysfunction | |
Maximum noradrenaline dose (μg/kg/min) | 0.16 [0.00–0.25] |
Need for renal replacement therapy | 7 (21) |
Comorbidities | |
Chronic obstructive pulmonary disease | 16 (48) |
Arterial hypertension | 22 (66) |
Coronary artery disease | 7 (21) |
Cardiac insufficiency | 6 (18) |
Chronic renal impairment | 2 (6) |
Stroke | 2 (6) |
Obesity | 9 (27) |
Ongoing treatments | |
Antiplatelet therapy | 10 (30) |
Anticoagulation | 4 (12) |
Home oxygen therapy | 11 (33) |
Home noninvasive ventilation | 4 (12) |